期刊文献+

Klotho蛋白与慢性肾脏病的相关研究进展

下载PDF
导出
摘要 Klotho基因最初被发现时是一组与衰老相关的基因,主要在肾脏表达,该基因的缺乏可导致寿命缩短、动脉粥样硬化、皮肤萎缩、高磷血症、骨质疏松等一系列表型[1],这些表型很多与慢性肾脏病(chroni ckidney disease,CKD)的临床表现具有高度的相似性。在不同病因导致的CKD包括慢性肾小球肾炎、梗阻性肾病、糖尿病肾脏疾病、高血压肾病、肾移植后慢性排异反应等,肾脏Klotho蛋白的转录及表达均下调,在CKD早期,
出处 《临床肾脏病杂志》 2013年第10期475-478,共4页 Journal Of Clinical Nephrology
基金 2012广西研究生教育创新计划项目(NQYCSZ2012035)
  • 相关文献

参考文献5

二级参考文献112

  • 1Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol, 2004, 15: 2208-2218.
  • 2ADHR Consortium. Autosomal dominant hypophpsphataemic richets is associated with mutations in FGF23. Nat Genet, 2000, 26: 345-348.
  • 3Benet-PagesA, Orlik P, Strom TM, et al. An FGF23 missense mutation causes familial tumoral c.alcinosis with hyperphosphatemia. Hum Mol Genet, 2005, 14: 385-390.
  • 4Tenenhouse HS, Sabbagh Y. Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders. Pflugers Arch, 2002, 444: 317-326.
  • 5Saito H, Kusano K, Kinosaki M, et al. Hmnan fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and lalpha, 25-dihyd-roxyvitamin D3 production. J Biol Chem, 2003, 278: 2206-2211.
  • 6Larsson T, Marsell R, Schipani E, et al. Transgenic mice expressing fibroblast growth faetor-23 under the eontrol of the alphal (1) collagen promoter exhibit growth retardation, osteomalaeia and disturbed phosphate homeostasis. Endocrinology, 2004, 145: 3087-3094.
  • 7Razzaque MS, St-Arnaud R, Taguchi T, et al. FGF23, vitamin D and calcification:the unholy triad. Nephrol Dial Transplant, 2005, 20: 2032-2035.
  • 8Deluca S, Sitara D, Kang K, et al. Amelioration of the premature aging-like features of FGF23 knockout mice by genetieally restoring the systemic aclions of FCF23. J Pathol, 2008, 216: 345-355.
  • 9Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth fhctor-23 mitigates hyperphosphatemia but accentuates ealcitriol deficieney in chronic kidney disease. J Am Soc Nephrol, 2005, 16: 2205-2215.
  • 10Larsson T, Nisbeth U, I,junggren O, et al. Circulating eoncentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int, 2003, 64: 2272-2279.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部